Publications by authors named "L Arriaga-Pizano"

Background: Allogeneic hematopoietic stem cell transplantation (HSCT) is a therapy that offers the potential to cure hematological malignancies. One limitation is that only 25% of patients will have an identical donor. The use of haploidentical donors allows 95% of patients to have a donor.

View Article and Find Full Text PDF

With the increase in the number of people with advanced age (> 60 years) worldwide, it is necessary to understand the processes that lead to healthy aging. Cellular senescence, immunosenescence and inflammaging are part of the natural process of aging and are associated with age-related diseases. Cellular senescence is characterized by the arrest of the cell cycle in the G1 phase.

View Article and Find Full Text PDF

Congenital heart disease (CHD) can be complicated by pulmonary arterial hypertension (PAH). Cardiopulmonary bypass (CPB) for corrective surgery may cause endothelial dysfunction, involving endothelin-1 (ET-1), circulating endothelial cells (CECs), and endothelial progenitor cells (EPCs). These markers can gauge disease severity, but their levels in children's peripheral blood still lack consensus for prognostic value.

View Article and Find Full Text PDF
Article Synopsis
  • Cell migration plays a crucial role in the immune system, but it is not well-studied in pregnant animals, despite observed increases in spleen and lymph node sizes during pregnancy.
  • In the study, researchers used a mouse model to analyze the movement of PKH26-stained immune cells from pregnant and non-pregnant mice to see how pregnancy affects cell distribution in lymphoid organs.
  • Results showed that while more thymocytes were present in females compared to males, the movement of immune cells from pregnant and non-pregnant mice was similar, suggesting that larger spleen and lymph node sizes in pregnant mice may be due to leukocyte retention rather than differences in cell migration.
View Article and Find Full Text PDF

Introduction: Several effective vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed and implemented in the population. However, the current production capacity falls short of meeting global demand. Therefore, it is crucial to further develop novel vaccine platforms that can bridge the distribution gap.

View Article and Find Full Text PDF